Billionaire Li Ka-Shing’s Drug Maker Hutchmed Sells $608 Million Stake In Cardiovascular Joint Venture
Li Ka-shing, senior advisor of CK Hutchison, which controls Hutchmed. Zhang Wei/China News Service/Visual China Group via Getty Images Hutchmed, a biopharmaceutical company controlled by Hong Kong’s wealthiest person Li Ka-shing, is divesting a 45% …